Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Pregnancy-Associated Breast Cancer

  • Fertility Issues and Breast Cancer (J Jeruss, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Pregnancy-associated breast cancer (PABC) is the most common malignancy diagnosed in women of childbearing age and is increasing in frequency as the average age of pregnancy rises. Outcomes for PABC are similar to age- and stage-matched controls. In this review, we discuss current treatment recommendations for PABC.

Recent Findings

Treatment of PABC involves complex coordination by a multi-disciplinary team of providers including surgical, radiation, and medical specialists. The timing and administration of these therapies must be tailored to account for the pregnancy in order to keep both woman and fetus safe. Additional data is needed on the safety of newer breast cancer therapies during pregnancy.

Summary

With close oversight, breast cancer therapy can be delivered effectively for the patient and safely for the developing fetus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128–35. https://doi.org/10.1067/s0002-9378(03)00537-4.

    Article  PubMed  Google Scholar 

  2. Hoover HC Jr. Breast cancer during pregnancy and lactation. Surg Clin North Am. 1990;70(5):1151–63. https://doi.org/10.1016/s0039-6109(16)45236-9.

    Article  PubMed  Google Scholar 

  3. Gwyn K, Theriault R. Breast cancer during pregnancy. Oncology (Williston Park). 2001;15(1):39–46 discussion, 9-51.

    CAS  Google Scholar 

  4. Lee YY, Roberts CL, Dobbins T, Stavrou E, Black K, Morris J, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994-2008: a population-based linkage study. BJOG. 2012;119(13):1572–82. https://doi.org/10.1111/j.1471-0528.2012.03475.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. • Shachar SS, Gallagher K, McGuire K, Zagar TM, Faso A, Muss HB, et al. Multidisciplinary management of breast cancer during pregnancy. Oncologist. 2017;22(3):324–34. https://doi.org/10.1634/theoncologist.2016-0208This paper highlights the importance of a multi-disciplnary team in the management of PABC in not only determining the best treatment course but also the timing of each treatment to maximize the safety of both the mother and fetus.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Robbins J, Jeffries D, Roubidoux M, Helvie M. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation. AJR Am J Roentgenol. 2011;196(3):716–22. https://doi.org/10.2214/AJR.09.3662.

    Article  PubMed  Google Scholar 

  7. • Vashi R, Hooley R, Butler R, Geisel J, Philpotts L. Breast imaging of the pregnant and lactating patient: physiologic changes and common benign entities. AJR Am J Roentgenol. 2013;200(2):329–36. https://doi.org/10.2214/AJR.12.9845This paper discusses breast imaging techniques during pregnancy and lactation for both the diagnosis and staging of PABC. It also reviews the differential for changes within the breast during pregnancy and in lactating women.

    Article  PubMed  Google Scholar 

  8. Nguyen CP, Goodman LH. Fetal risk in diagnostic radiology. Semin Ultrasound CT MR. 2012;33(1):4–10. https://doi.org/10.1053/j.sult.2011.09.003.

    Article  PubMed  Google Scholar 

  9. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003;138(1):91–8; discussion 9. https://doi.org/10.1001/archsurg.138.1.91.

    Article  PubMed  Google Scholar 

  10. Zanotti-Fregonara P, Laforest R, Wallis JW. Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/MR. J Nucl Med. 2015;56(8):1218–22. https://doi.org/10.2967/jnumed.115.157032.

    Article  CAS  PubMed  Google Scholar 

  11. Zanotti-Fregonara P, Stabin MG. New fetal radiation doses for (18)F-FDG based on human data. J Nucl Med. 2017;58(11):1865–6. https://doi.org/10.2967/jnumed.117.195404.

    Article  CAS  PubMed  Google Scholar 

  12. Asgeirsson KS. Pregnancy-associated breast cancer. Acta Obstet Gynecol Scand. 2011;90(2):158–66. https://doi.org/10.1111/j.1600-0412.2010.01035.x.

    Article  PubMed  Google Scholar 

  13. • Murphy CG, Mallam D, Stein S, Patil S, Howard J, Sklarin N, et al. Current or recent pregnancy is associated with adverse pathologic features but not impaired survival in early breast cancer. Cancer. 2012;118(13):3254–9. https://doi.org/10.1002/cncr.26654This paper discusses adverse pathologic features specific to PABC and how this may affect treatment and survival.

    Article  PubMed  Google Scholar 

  14. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41. https://doi.org/10.1056/NEJMoa022152.

    Article  PubMed  Google Scholar 

  15. •• Feng C, Yu D, Qian J. Long-term results and predictors of survival after conservative breast surgery for breast cancer during pregnancy. Med Sci Monit. 2019;25:8587–94. https://doi.org/10.12659/MSM.917288This paper evaluates similar long-term survival rates in women with PABC and non-pregnancy-related breast cancer, as well as predictors of survival in women with PABC after surgery.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gropper AB, Calvillo KZ, Dominici L, Troyan S, Rhei E, Economy KE, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014;21(8):2506–11. https://doi.org/10.1245/s10434-014-3718-2.

    Article  PubMed  Google Scholar 

  17. Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CE, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol. 2009;16(5):1143–7. https://doi.org/10.1245/s10434-009-0390-z.

    Article  PubMed  Google Scholar 

  18. Paskulin GA, Gazzola Zen PR, de Camargo Pinto LL, Rosa R, Graziadio C. Combined chemotherapy and teratogenicity. Birth Defects Res A Clin Mol Teratol. 2005;73(9):634–7. https://doi.org/10.1002/bdra.20180.

    Article  CAS  PubMed  Google Scholar 

  19. •• de Haan J, Verheecke M, Van Calsteren K, Van Calster B, Shmakov RG, Mhallem Gziri M, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–46. https://doi.org/10.1016/S1470-2045(18)30059-7This is one of the largest cohort studies that reviews long-term neonatal and patient outcomes with PABC.

    Article  PubMed  Google Scholar 

  20. Cardonick E, Dougherty R, Grana G, Gilmandyar D, Ghaffar S, Usmani A. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J. 2010;16(1):76–82. https://doi.org/10.1097/PPO.0b013e3181ce46f9.

    Article  PubMed  Google Scholar 

  21. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer. 2006;107(6):1219–26. https://doi.org/10.1002/cncr.22081.

    Article  PubMed  Google Scholar 

  22. Sukumvanich P. Review of current treatment options for pregnancy-associated breast cancer. Clin Obstet Gynecol. 2011;54(1):164–72. https://doi.org/10.1097/GRF.0b013e3182083a44.

    Article  PubMed  Google Scholar 

  23. Cardonick E. Pregnancy-associated breast cancer: optimal treatment options. Int J Womens Health. 2014;6:935–43. https://doi.org/10.2147/IJWH.S52381.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Ring AE, Smith IE, Jones A, Shannon C, Galani E, Ellis PA. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals. J Clin Oncol. 2005;23(18):4192–7. https://doi.org/10.1200/JCO.2005.03.038.

    Article  PubMed  Google Scholar 

  25. Peccatori FA, Azim HA Jr, Scarfone G, Gadducci A, Bonazzi C, Gentilini O, et al. Weekly epirubicin in the treatment of gestational breast cancer (GBC). Breast Cancer Res Treat. 2009;115(3):591–4. https://doi.org/10.1007/s10549-008-0159-2.

    Article  CAS  PubMed  Google Scholar 

  26. • Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi160–70. https://doi.org/10.1093/annonc/mdt199This paper includes key practice guidelines for the diagnosis and management of PABC.

    Article  PubMed  Google Scholar 

  27. Cardonick E, Bhat A, Gilmandyar D, Somer R. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol. 2012;23(12):3016–23. https://doi.org/10.1093/annonc/mds170.

    Article  CAS  PubMed  Google Scholar 

  28. Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol. 2012;120(6):1267–72. https://doi.org/10.1097/AOG.0b013e31826c32d9.

    Article  CAS  PubMed  Google Scholar 

  29. Maly JJ, Macrae ER. Pertuzumab in combination with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer: safety, efficacy, and progression free survival. Breast Cancer (Auckl). 2014;8:81–8. https://doi.org/10.4137/BCBCR.S9032.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(2):349–57. https://doi.org/10.1007/s10549-012-2368-y.

    Article  CAS  PubMed  Google Scholar 

  31. Witzel ID, Muller V, Harps E, Janicke F, Dewit M. Trastuzumab in pregnancy associated with poor fetal outcome. Ann Oncol. 2008;19(1):191–2. https://doi.org/10.1093/annonc/mdm542.

    Article  CAS  PubMed  Google Scholar 

  32. Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006;355(26):2733–43. https://doi.org/10.1056/NEJMoa064320.

    Article  CAS  PubMed  Google Scholar 

  33. Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R. Use of tamoxifen before and during pregnancy. Oncologist. 2011;16(11):1547–51. https://doi.org/10.1634/theoncologist.2011-0121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Bonilla L, Ben-Aharon I, Vidal L, Gafter-Gvili A, Leibovici L, Stemmer SM. Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst. 2010;102(24):1845–54. https://doi.org/10.1093/jnci/djq409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368(9):814–23. https://doi.org/10.1056/NEJMoa1211035.

    Article  CAS  PubMed  Google Scholar 

  36. Ajioka H, Morita F, Akizawa Y, Yoshida K, Kitamura R, Takimoto H. Pharmacological, pharmacokinetic, and clinical profile of palonosetron hydrochloride (ALOXI I.V. Injection 0.75 mg), a novel antiemetic 5-HT3-receptor antagonist. Nihon Yakurigaku Zasshi. 2010;136(2):113–20. https://doi.org/10.1254/fpj.136.113.

    Article  CAS  PubMed  Google Scholar 

  37. Dilly S. Granisetron (Kytril) clinical safety and tolerance. Semin Oncol. 1994;21(3 Suppl 5):10–4.

    CAS  PubMed  Google Scholar 

  38. Paizis K. Immunomodulatory drugs in pregnancy and lactation. Aust Prescr. 2019;42(3):97–101. https://doi.org/10.18773/austprescr.2019.026.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Griffin SJ, Milla M, Baker TE, Liu T, Wang H, Hale TW. Transfer of carboplatin and paclitaxel into breast milk. J Hum Lact. 2012;28(4):457–9. https://doi.org/10.1177/0890334412459374.

  40. LactMed. Drugs and Lactation Database: technetium Tc 99m sulfur colloid. https://www.ncbi.nlm.nih.gov/books/NBK501582/. Accessed 1 Sept 2020.

  41. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17(3):855–61. https://doi.org/10.1200/JCO.1999.17.3.855.

    Article  CAS  PubMed  Google Scholar 

  42. van der Linden W, Bergman F. Gallstone formation in mice. Effects of chenodesoxycholic acid compared with cholic acid. Nord Med. 1971;85(7):219.

    PubMed  Google Scholar 

  43. Aviles A, Neri N, Nambo MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol. 2006;17(2):286–8. https://doi.org/10.1093/annonc/mdj053.

    Article  CAS  PubMed  Google Scholar 

  44. Aviles A, Nambo MJ, Huerta-Guzman J, Neri N, Cleto S. Speckle-tracking echocardiography to detect cardiac toxicity in children who received anthracyclines during pregnancy. Clin Lymphoma Myeloma Leuk. 2016;16(1):1–4. https://doi.org/10.1016/j.clml.2015.09.009.

    Article  PubMed  Google Scholar 

  45. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012;13(3):256–64. https://doi.org/10.1016/S1470-2045(11)70363-1.

    Article  CAS  PubMed  Google Scholar 

  46. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001;2(3):173–7. https://doi.org/10.3816/clm.2001.n.023.

    Article  CAS  PubMed  Google Scholar 

  47. Clinicaltrials.gov. Effects of oncological treatment during pregnancy on mother and child. Retrieved September 1, 2020, from https://clinicaltrials.gov/ct2/show/NCT00330447.

Download references

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, Emory University, Atlanta, GA, USA

    Manali A. Bhave

  2. Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, NCRC 26-319S, SPC 2800 Plymouth Rd., Ann Arbor, MI, 48109-2800, USA

    Monika L. Burness

Authors
  1. Manali A. Bhave
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Monika L. Burness
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika L. Burness.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Manali Bhave and Monika Burness declare that they have no conflict of interest

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Fertility Issues and Breast Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhave, M.A., Burness, M.L. Treatment of Pregnancy-Associated Breast Cancer. Curr Breast Cancer Rep 13, 81–86 (2021). https://doi.org/10.1007/s12609-021-00406-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-021-00406-2

Keywords

Search

Navigation